$UTHR 8-K SEC Filings

Filed On	Filing
22 Oct 2026	8-K: Other Events SILVER SPRING, M.D. and RESEARCH TRIANGLE PARK, N.C., October 22, 2026: United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the company’s Board of Directors has authorized a new share repurc...
14 Oct 2026	8-K: Other Events This Settlement Agreement (this “Agreement”) is made and entered into as of the last date of signature of this Agreement (the “Execution Date”), by and between United Therapeutics Corporation, a Delaware public benefit corporation with a...
08 Sep 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure United Therapeutics Corporation Announces Accelerated Share Repurchase Agreement for Remainder of $2.0 Billion Authorization
05 Aug 2026	8-K: Results of Operations and Financial Condition
23 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
29 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
06 May 2026	8-K: Results of Operations and Financial Condition
30 Mar 2026	8-K: Other Events
09 Mar 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
02 Mar 2026	8-K: Regulation FD Disclosure
25 Feb 2026	8-K: Results of Operations and Financial Condition
22 Jan 2026	8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more
29 Oct 2025	8-K: Results of Operations and Financial Condition
02 Sep 2025	8-K: Other Events
01 Aug 2025	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
30 Jul 2025	8-K: Results of Operations and Financial Condition
27 Jun 2025	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
30 Apr 2025	8-K: Results of Operations and Financial Condition
28 Apr 2025	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +1 more
26 Feb 2025	8-K: Results of Operations and Financial Condition

Comments